R&D Six life sciences real estate trends to watch in 2025 Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs.
R&D JP Morgan Week 2025 - Fabrizio Chines In this video from JPM 2025, pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.
R&D Rare disease and the women's health gap For women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed.
R&D 5 takeaways from JP Morgan 2025 I’m back from another week in San Francisco, where as usual I heard from experts and prognosticators about their expectations for the coming year in biotech.
R&D The future of precision psychiatry The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and
R&D Changing Faces: Pharma and biotech November-December 2024 Welcome to the last edition of Changing Faces for 2024.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
